Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

1.74
+0.290020.00%
Volume:3.87M
Turnover:6.64M
Market Cap:356.70M
PE:-4.87
High:1.80
Open:1.47
Low:1.46
Close:1.45
Loading ...
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 19, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Sep 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Correspondence

Form CORRESP - Correspondence
Aug 29, 2023

Major Issues Report

Form 8-K - Current report
Aug 28, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals